{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:11:42Z","timestamp":1791267102541,"version":"4.1.0"},"reference-count":31,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2018,3,28]]},"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to evaluate the effectiveness of multiple risk factor control (MRFC) at reducing mortality and cardiovascular events in diabetes and chronic kidney disease (CKD) in clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Population-based cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>Primary care database in the UK, linked with inpatient and mortality data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>\n                      Participants aged 40\u201379 years with type 2 diabetes and valid serum creatinine measurements, including 11\u2009431 participants with CKD (estimated glomerular filtration rate: eGFR 15\u201359\u2009mL\/min\/1.73\u2009m\n                      <jats:sup>2<\/jats:sup>\n                      ) and 36\u2009429 participants with non-CKD (eGFR \u226560\u2009mL\/min\/1.73\u2009m\n                      <jats:sup>2<\/jats:sup>\n                      ).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>MRFC consisted of four components: Haemoglobin A1c (HbA1c) &lt;53\u2009mmol\/mol (&lt;7.0%), blood pressure &lt;140\/90\u2009mm Hg, total cholesterol &lt;5\u2009mmol\/L and no smoking. The main exposure variable was the number of risk factors controlled at baseline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcome measures<\/jats:title>\n                    <jats:p>All-cause and cardiovascular mortality in the overall participants. Cardiovascular events, including coronary heart disease and stroke, in participants limited to those without a history of cardiovascular diseases at baseline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In participants with CKD, 37% or 13% met three or four MRFC criteria, respectively. Increasing numbers of risk factors controlled were associated with lower relative hazards for all outcomes studied compared with those meeting no or one criterion. For participants with CKD meeting four criteria, the adjusted HR for all-cause mortality was 0.60 (95% CI 0.53 to 0.69) and the adjusted subdistribution HR for cardiovascular mortality was 0.60 (95% CI 0.50 to 0.70), considering a competing risk of non-cardiovascular death. Participants meeting four criteria also had lower relative hazards for coronary heart disease (adjusted subdistribution HR 0.73, 95%\u2009CI 0.59 to 0.91) and stroke (0.63, 95% CI 0.45 to 0.89), considering death as a competing risk.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MRFC may lower the increased risks for mortality and cardiovascular events in people with diabetes and CKD. Further research is needed to evaluate appropriateness of MRFC according to individual participants\u2019 health status for improved management of cardiovascular risks in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2017-019950","type":"journal-article","created":{"date-parts":[[2018,5,8]],"date-time":"2018-05-08T03:55:12Z","timestamp":1525751712000},"page":"e019950","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":25,"title":["Multiple risk factor control, mortality and cardiovascular events in type 2 diabetes and chronic kidney disease: a population-based cohort study"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4939-1834","authenticated-orcid":false,"given":"Shota","family":"Hamada","sequence":"first","affiliation":[{"name":"Department of Primary Care and Public Health Sciences, King\u2019s College London, London, UK"},{"name":"Research Department, Institute for Health Economics and Policy, Association for Health Economics Research and Social Insurance and Welfare, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C","family":"Gulliford","sequence":"additional","affiliation":[{"name":"Department of Primary Care and Public Health Sciences, King\u2019s College London, London, UK"},{"name":"National Institute for Health Research Biomedical Research Centre, Guy\u2019s and St Thomas\u2019 National Health Service Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,5,8]]},"reference":[{"key":"2025121408495269000_8.5.e019950.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61682-2"},{"key":"2025121408495269000_8.5.e019950.2","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-015-0268-9"},{"key":"2025121408495269000_8.5.e019950.3","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs269"},{"key":"2025121408495269000_8.5.e019950.4","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2015050542"},{"key":"2025121408495269000_8.5.e019950.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806470"},{"key":"2025121408495269000_8.5.e019950.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041031"},{"key":"2025121408495269000_8.5.e019950.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021778"},{"key":"2025121408495269000_8.5.e019950.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706245"},{"key":"2025121408495269000_8.5.e019950.9","doi-asserted-by":"publisher","DOI":"10.1177\/1479164113496828"},{"key":"2025121408495269000_8.5.e019950.10","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-2439"},{"key":"2025121408495269000_8.5.e019950.11","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1877"},{"key":"2025121408495269000_8.5.e019950.12","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-015-0204-5"},{"key":"2025121408495269000_8.5.e019950.13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamainternmed.2015.6102","article-title":"Representation of Patients With Kidney Disease in Trials of Cardiovascular Interventions: An Updated Systematic Review","volume":"176","author":"Konstantinidis","year":"2016","journal-title":"JAMA Intern Med"},{"key":"2025121408495269000_8.5.e019950.14","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv098"},{"key":"2025121408495269000_8.5.e019950.15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068008","article-title":"Recent HbA1c values and mortality risk in type 2 diabetes. population-based case-control study","volume":"8","author":"Nicholas","year":"2013","journal-title":"PLoS One"},{"key":"2025121408495269000_8.5.e019950.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4070"},{"key":"2025121408495269000_8.5.e019950.17","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2025121408495269000_8.5.e019950.18","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-014-3473-8"},{"key":"2025121408495269000_8.5.e019950.19","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00125-015-3548-1","article-title":"Blood pressure level and risk of major cardiovascular events and all-cause of mortality in patients with type 2 diabetes and renal impairment: an observational study from the Swedish National Diabetes Register","volume":"58","author":"Afghahi","year":"2015","journal-title":"Diabetologia"},{"key":"2025121408495269000_8.5.e019950.20","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/HYPERTENSIONAHA.116.08386","article-title":"Evidence for Reverse Causality in the Association Between Blood Pressure and Cardiovascular Risk in Patients With Chronic Kidney Disease","volume":"69","author":"Herrington","year":"2017","journal-title":"Hypertension"},{"key":"2025121408495269000_8.5.e019950.21","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1525-1497.2004.40049.x","article-title":"Managing dyslipidemia in chronic kidney disease","volume":"19","author":"Weiner","year":"2004","journal-title":"J Gen Intern Med"},{"key":"2025121408495269000_8.5.e019950.22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007168","article-title":"Selection of medical diagnostic codes for analysis of electronic patient records. Application to stroke in a primary care database","volume":"4","author":"Gulliford","year":"2009","journal-title":"PLoS One"},{"key":"2025121408495269000_8.5.e019950.23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029776","article-title":"Coding, recording and incidence of different forms of coronary heart disease in primary care","volume":"7","author":"Bhattarai","year":"2012","journal-title":"PLoS One"},{"key":"2025121408495269000_8.5.e019950.24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.017719"},{"key":"2025121408495269000_8.5.e019950.25","unstructured":"Gordon M , Lumley T . Advanced forest plot using \u2019grid' graphics. Vienna: The Comprehensive R Archive Network, 2016."},{"key":"2025121408495269000_8.5.e019950.26","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn018"},{"key":"2025121408495269000_8.5.e019950.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60834-3"},{"key":"2025121408495269000_8.5.e019950.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60674-5"},{"key":"2025121408495269000_8.5.e019950.29","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","article-title":"Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data","volume":"3","author":"Matsushita","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025121408495269000_8.5.e019950.30","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcn177"},{"key":"2025121408495269000_8.5.e019950.31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2014-000071","article-title":"Monitoring for proteinuria in patients with type 2 diabetes mellitus","volume":"3","author":"Liang","year":"2015","journal-title":"BMJ Open Diabetes Res Care"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-019950","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:50:00Z","timestamp":1765731000000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-019950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,8]]},"published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1136\/bmjopen-2017-019950"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-019950","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}